Prevalence of chronic kidney disease stages 3-5 among acute medical admissions: another opportunity for screening.

BACKGROUND Early identification of chronic kidney disease (CKD) can help delay or prevent its progression, but the opportunities for systematic screening of patients are not well defined. AIM To define the prevalence of CKD Stages 3-5 and related anaemia among acute medical admissions. DESIGN Retrospective analysis. METHODS We studied all acute medical admissions to a major London teaching hospital during one year. The lowest creatinine, highest haemoglobin (Hb) and average mean corpuscular volume (MCV) were determined for 3 months before and after admission. Patients were categorized as CKD Stages 3-5 if the highest estimated GFR (eGFR) was <60 ml/min/1.73 m2. CKD-related anaemia was diagnosed if these patients had Hb <11 g/dl with normal MCV. RESULTS A total of 6073 patients were studied: male 49.0%, age 65.4 +/- 19.6 years (mean +/- SD), creatinine 82.7 +/- 46.7 micromol/l, eGFR 89.1 +/- 32.5 ml/min/1.73 m2, Hb 13.6 +/- 1.73 g/dl, MCV 87.7 +/- 7.2 fl. There was an inverse correlation between eGFR and age (r2 = 0.5; P < 0.001). Males were younger than females (63.5 +/- 18.4 years vs. 67.3 +/- 20.5) and had higher eGFR (93.6 +/- 34.1 vs. 84.7 +/- 30.2 ml/min/1.73 m2; P < 0.001). A total of 743 patients (12.2%) had raised creatinine >110 micromol/l, however using eGFR <60 ml/min/1.73 m2, 1075 patients (17.7%) were identified. The patients were categorized as follows: Stage 3: 950 (15.6%), Stage 4: 100 (1.7%), Stage 5: 25 (0.4%). Ninety-nine (9.2%) of the 1075 patients had normocytic anaemia. CONCLUSION We have found a high prevalence of CKD Stages 3-5 (17.7%) among acute medical admissions, of whom 9.2% had a related anaemia. Our findings highlight an important opportunity (amongst the 1.9 million acute medical admissions annually in England) for detecting patients with CKD.

[1]  Fang Wang,et al.  Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  H. Krum,et al.  Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis , 2007, The Lancet.

[3]  H. Burger,et al.  Normalization of hemoglobin level in patients with chronic kidney disease and anemia. , 2006, The New England journal of medicine.

[4]  Huiman Barnhart,et al.  Correction of anemia with epoetin alfa in chronic kidney disease. , 2006, The New England journal of medicine.

[5]  B. Robinson.  Epidemiology of chronic kidney disease and anemia. , 2006, Journal of the American Medical Directors Association.

[6]  F. Dekker,et al.  Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey , 2006, BMJ : British Medical Journal.

[7]  N. Powe,et al.  International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. , 2006, Journal of the American Society of Nephrology : JASN.

[8]  Wim Van Biesen,et al.  Chronic kidney disease: a European perspective. , 2005, Kidney international. Supplement.

[9]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[10]  R. Atkins,et al.  A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004. , 2005, Kidney international. Supplement.

[11]  A. Bello,et al.  Chronic kidney disease: the global challenge , 2005, The Lancet.

[12]  Zhongxin Zhang,et al.  Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. , 2004, Kidney international.

[13]  P. Stevens,et al.  Unreferred chronic kidney disease: a longitudinal study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  P. Stevens,et al.  Clinical management of anaemia pre-endstage renal failure. , 2003, Clinical medicine.

[15]  J. Coresh,et al.  Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. , 2003, Kidney international.

[16]  C. McCulloch,et al.  Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. , 2002, Journal of the American Society of Nephrology : JASN.

[17]  D C Wheeler,et al.  Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  S. Yusuf,et al.  Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.

[19]  S. Pudaric,et al.  Cardiovascular Disease Risk Factors Among Older Black, Mexican‐American, and White Women and Men: An Analysis of NHANES III, 1988–1994 , 2001, Journal of the American Geriatrics Society.

[20]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[21]  M. Domanski,et al.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. , 2000, Journal of the American College of Cardiology.

[22]  D. Levy,et al.  Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. , 1999, Kidney international.

[23]  J. Singer,et al.  Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  H. Kraemer,et al.  Ethnic and Socioeconomic Differences in Cardiovascular Disease Risk Factors: Findings for Women From the Third National Health and Nutrition Examination Survey, 1988-1994 , 1999 .

[25]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[26]  H. Kraemer,et al.  Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. , 1998, JAMA.

[27]  M. Blaufox,et al.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.

[28]  K. Maurer,et al.  Third national health and nutrition examination survey , 1985 .

[29]  K. Cardarelli,et al.  Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. , 2007, Ethnicity & disease.

[30]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  E. Beutner,et al.  Report of a WHO Scientific Group (Part 3 of 3) , 1973 .

[32]  B. Blanc.  Nutritional anemias. Report of a WHO Scientific Group , 1968 .